These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35803515)

  • 1. Clinical evidence of outcomes following liver transplantation in patients with nonalcoholic steatohepatitis: An updated meta-analysis and systematic review.
    Zhou GP; Jiang YZ; Sun LY; Zhu ZJ
    Int J Surg; 2022 Aug; 104():106752. PubMed ID: 35803515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review.
    Yong JN; Lim WH; Ng CH; Tan DJH; Xiao J; Tay PWL; Lin SY; Syn N; Chew N; Nah B; Dan YY; Huang DQ; Tan EXX; Sanyal AJ; Noureddin M; Siddiqui MS; Muthiah MD
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):45-54.e6. PubMed ID: 34801743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis.
    Wang X; Li J; Riaz DR; Shi G; Liu C; Dai Y
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):394-402.e1. PubMed ID: 24076414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of liver transplantation in non-alcoholic steatohepatitis (NASH) versus non-NASH associated hepatocellular carcinoma.
    Rajendran L; Murillo Perez CF; Ivanics T; Claasen MPAW; Hansen BE; Wallace D; Yoon PD; Sapisochin G
    HPB (Oxford); 2023 May; 25(5):556-567. PubMed ID: 36828740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium.
    Kwong AJ; Devuni D; Wang C; Boike J; Jo J; VanWagner L; Serper M; Jones L; Sharma R; Verna EC; Shor J; German MN; Hristov A; Lee A; Spengler E; Koteish AA; Sehmbey G; Seetharam A; John N; Patel Y; Kappus MR; Couri T; Paul S; Salgia RJ; Nhu Q; Frenette CT; Lai JC; Goel A;
    Liver Transpl; 2020 Nov; 26(11):1492-1503. PubMed ID: 33047893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.
    Sadler EM; Mehta N; Bhat M; Ghanekar A; Greig PD; Grant DR; Yao F; Sapisochin G
    Transplantation; 2018 Apr; 102(4):640-647. PubMed ID: 29319620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
    Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
    Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Holzner ML; Florman S; Schwartz ME; Tabrizian P
    HPB (Oxford); 2022 Apr; 24(4):470-477. PubMed ID: 34544629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
    Wong RJ; Cheung R; Ahmed A
    Hepatology; 2014 Jun; 59(6):2188-95. PubMed ID: 24375711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
    Yuan L; Hanlon CL; Terrault N; Alqahtani S; Tamim H; Lai M; Saberi B
    Am J Gastroenterol; 2022 Mar; 117(3):433-444. PubMed ID: 35083985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of patient survival following liver transplant in non-alcoholic steatohepatitis: A systematic review and meta-analysis.
    Minich A; Arisar FAQ; Shaikh NS; Herman L; Azhie A; Orchanian-Cheff A; Patel K; Keshavarzi S; Bhat M
    EClinicalMedicine; 2022 Aug; 50():101534. PubMed ID: 35812989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
    Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
    Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma.
    Hernandez-Alejandro R; Croome KP; Drage M; Sela N; Parfitt J; Chandok N; Marotta P; Dale C; Wall W; Quan D
    World J Gastroenterol; 2012 Aug; 18(31):4145-9. PubMed ID: 22919246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
    Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
    Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.